Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Opioid Abuse)
30,368 results
  • Cebranopadol: novel dual opioid/NOP receptor agonist analgesic. [Review]
  • JCJ Clin Pharm Ther 2016 Oct 24
  • Raffa RB, Burdge G, … Watkins TN
  • CONCLUSIONS: Despite the medical need, a truly novel centrally acting analgesic has not been developed in many years. Cebranopadol represents a truly novel mechanistic approach. Its actual place in pain pharmacotherapy awaits the results of phase 3 clinical trials.
New Search Next